SECONDARY MECHANISMS IN NEURONAL TRAUMA

被引:132
作者
LYNCH, DR
DAWSON, TM
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL & NEUROSCI, BALTIMORE, MD 21287 USA
[2] UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1097/00019052-199412000-00007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Secondary damage in central nervous system trauma results from toxic effects of a variety of modulators that magnify the initial traumatic damage. These modulators include the excitatory transmitter glutamate, the intracellular messenger calcium, and the intercellular messenger nitric oxide. Glutamate-induced toxicity, called excitotoxicity, occurs from excess glutamate release following trauma. Passage of calcium into the cell through a specific postsynaptic glutamate receptor ion channel, the N-methyl-D-aspartate (NMDA) receptor, is crucial in activating cellular pathways leading to excitotoxic damage. The NMDA receptor requires both glutamate and glycine for activation and is blocked by many drugs that act at either of these sites. It is also blocked by agents that selectively block the ion channel of this receptor. Blocking NMDA receptors at any of these sites decreases the cellular damage mediated by glutamate in neuronal trauma and improves physiological measures associated with traumatic damage. Other strategies to limit secondary damage include blockade of other calcium channels, of calcium-activated enzymes, and of processes that mediate the effects of calcium. Calcium-activated enzymes include nitric oxide synthase and phospholipases, which cause production of free radicals. In combination with NMDA receptor blockade, these sites represent promising areas for therapeutic intervention in secondary traumatic damage.
引用
收藏
页码:510 / 516
页数:7
相关论文
共 50 条
  • [1] BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53
  • [2] BENEVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131
  • [3] NEUROPROTECTIVE EFFICACY OF N-OMEGA-NITRO-L-ARGININE AFTER FOCAL CEREBRAL-ISCHEMIA IN THE MOUSE AND INHIBITION OF CORTICAL NITRIC-OXIDE SYNTHASE
    CARREAU, A
    DUVAL, D
    POIGNET, H
    SCATTON, B
    VIGE, X
    NOWICKI, JP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 256 (03) : 241 - 249
  • [4] CHAN PH, 1992, J NEUROTRAUM, V9, pS417
  • [5] CHOI D, 1988, TRENDS NEUROSCI, V7, P357
  • [6] OPTIMAL EXPRESSION OF CLONED NMDAR1 NMDAR2A HETEROMERIC GLUTAMATE RECEPTORS - A BIOCHEMICAL-CHARACTERIZATION
    CIK, M
    CHAZOT, PL
    STEPHENSON, FA
    [J]. BIOCHEMICAL JOURNAL, 1993, 296 : 877 - 883
  • [7] COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
  • [8] DAWSON TM, 1994, J NEUROSCI, V14, P5147
  • [9] A NOVEL NEURONAL MESSENGER MOLECULE IN BRAIN - THE FREE-RADICAL, NITRIC-OXIDE
    DAWSON, TM
    DAWSON, VL
    SNYDER, SH
    [J]. ANNALS OF NEUROLOGY, 1992, 32 (03) : 297 - 311
  • [10] DAWSON TM, 1994, IN PRESS NEUROSCIENT